G. Boka

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

G. Boka, Philippe Anglade, David Wallach et al. · Neuroscience Letters · 1994 · 594 citations

Life Sciences, Neurobiology, Neuroscience +14

Dose‐dependent effects of the once‐daily GLP‐1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double‐blind, placebo‐controlled trial

Robert E. Ratner, Julio Rosenstock, G. Boka · Diabetic Medicine · 2010 · 154 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal‐F1)

Geremia B. Bolli, Mihnea Munteanu, S. Ya. Dotsenko et al. · Diabetic Medicine · 2013 · 142 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Pharmacodynamics of the glucagon‐like peptide‐1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin

Yutaka Seino, Akiyoshi Takami, G. Boka et al. · Diabetes Obesity and Metabolism · 2014 · 28 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Testing the portal imager GLAaS algorithm for machine quality assurance

G. Nicolini, Eugenio Vanetti, Alessandro Clivio et al. · Radiation Oncology · 2008 · 13 citations · Full text

Engineering, Nuclear Engineering, Nuclear Instrumentation +16